Puma Biotechnology Inc (PBYI) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $7.60
• Market Cap: $387.00M
• P/E Ratio: 10.11
• EPS: $0.76
• 52-Week High: $7.68
• 52-Week Low: $2.58

Market Sentiment

Puma Biotechnology Inc currently has a Bullish sentiment score of 0.28.

About Puma Biotechnology Inc

Puma Biotechnology, Inc. is a biopharmaceutical firm based in Los Angeles that specializes in the development and commercialization of innovative cancer therapies aimed at enhancing treatment outcomes for patients globally. With a strong emphasis on precision medicine, Puma is advancing a proprietary pipeline of drug candidates targeting specific oncological indications, addressing crucial unmet needs in the oncology sector. The company's strategic positioning and commitment to innovation mak...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Puma Biotechnology Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PBYI pay dividends?

Puma Biotechnology Inc (PBYI) does not currently pay a regular dividend.

What is PBYI's P/E ratio?

Puma Biotechnology Inc has a price-to-earnings (P/E) ratio of 10.11.

What is PBYI's market cap?

Puma Biotechnology Inc (PBYI) has a market capitalization of $387.00M with a current stock price of $7.60.